<DOC>
	<DOCNO>NCT00827008</DOCNO>
	<brief_summary>The purpose study investigate long-term safety tolerability efficacy neramexane mesylate long-term treatment subjective tinnitus complete double-blind randomized placebo control study</brief_summary>
	<brief_title>Open-Label , Long-Term Treatment Study , Assess Long-Term Safety Tolerability Efficacy Neramexane Patients With Subjective Tinnitus</brief_title>
	<detailed_description />
	<mesh_term>Tinnitus</mesh_term>
	<criteria>Main Male female patient successfully complete one doubleblind Phase 3 tinnitus study Merz Neramexane mesylate patient age equal old 18 old 75 year clinical diagnosis first onset , persistent ( i.e . tinnitus never absent 24 hour row ) , subjective , unior bilateral subacute tinnitus timepoint leadin study Main clinical diagnosis intermittent pulsatile tinnitus Patients tinnitus concomitant symptom otological/neurological disease ( otitis medium , Meniére´s disease , otosclerosis etc . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>